3251 - 3260 of 9034 Results
Title
Year
-
OPENTitle: Modifiable Comorbidities Associated with Cognitive Decline in Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 8Issue #: 2Start Page: 254End Page: 263Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13143Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13143Citation Count: 16
-
OPENTitle: Dream Content Predicts Motor and Cognitive Decline in Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 8Issue #: 7Start Page: 1041End Page: 1051Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13318Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8485616Citation Count: 15
- Motor Complications in Parkinson's Disease: Results from 3343 Patients Followed for up to 12 Years2024OPENTitle: Motor Complications in Parkinson's Disease: Results from 3343 Patients Followed for up to 12 YearsJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 11Issue #: 6Start Page: 686End Page: 697Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.14044Best OA location URL: https://research-information.bris.ac.uk/en/publications/882c3e53-2aa7-4b20-9e98-9fa553842eb3Citation Count: 19
-
OPENTitle: Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 30Issue #: 7Start Page: 919End Page: 927Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.26170Best OA location URL: http://doi.org/10.1002/mds.26170Citation Count: 307
- Factors Influencing Patient Disclosure of Parkinson's Disease Genetic Testing Results to Relatives2024OPENTitle: Factors Influencing Patient Disclosure of Parkinson's Disease Genetic Testing Results to RelativesJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 11Issue #: 7Start Page: 786End Page: 794Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/mdc3.14043Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.14043Citation Count: 0
-
RESTRICTEDTitle: Diffusion tensor imaging of the nigrostriatal fibers in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 30Issue #: 9Start Page: 1229End Page: 1236Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26251Best OA location URL: http://doi.org/10.1002/mds.26251Citation Count: 115
- Longitudinal changes in CSF alpha‐synuclein species reflect Parkinson's disease progression2016OPENTitle: Longitudinal changes in CSF alpha‐synuclein species reflect Parkinson's disease progressionJournal Name: Movement DisordersPublisher: WileyVol: 31Issue #: 10Start Page: 1535End Page: 1542Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.26754Citation Count: 150
-
OPENTitle: Longitudinal Change of Clinical and Biological Measures in Early Parkinson's Disease: Parkinson's Progression Markers Initiative CohortJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 5Start Page: 771End Page: 782Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.27361Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.27361Citation Count: 204
- 123I‐FP‐CIT SPECT [(123) I‐2β‐carbomethoxy‐3β‐(4‐iodophenyl)‐N‐(3‐fluoropropyl) nortropane single photon emission computed tomography] Imaging in a p.A53T α‐synuclein Parkinson's disease cohort versus Parkinson's disease2018RESTRICTEDTitle: 123I‐FP‐CIT SPECT [(123) I‐2β‐carbomethoxy‐3β‐(4‐iodophenyl)‐N‐(3‐fluoropropyl) nortropane single photon emission computed tomography] Imaging in a p.A53T α‐synuclein Parkinson's disease cohort versus Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 11Start Page: 1734End Page: 1739Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27451Citation Count: 13
-
OPENTitle: Clinical and Dopamine Transporter Imaging Characteristics of Leucine Rich Repeat Kinase 2 (LRRK2) and Glucosylceramidase Beta (GBA) Parkinson's Disease Participants in the Parkinson's Progression Markers Initiative: A Cross‐Sectional StudyJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 5Start Page: 833End Page: 844Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.27989Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.27989Citation Count: 84